Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer

被引:57
|
作者
Pinaquy, Jean-Baptiste [1 ]
De Clermont-Galleran, Henri [1 ,2 ]
Pasticier, Gilles [3 ]
Rigou, Gerald [4 ]
Alberti, Nicolas [4 ]
Hindie, Elif [1 ,2 ]
Mokrane, Yacoub [5 ]
Fernandez, Philippe [1 ,2 ]
机构
[1] Hop Pellegrin, Dept Nucl Med, F-33076 Bordeaux, France
[2] Univ Bordeaux, INCIA, UMR CNRS 5287, Bordeaux, France
[3] Hop Pellegrin, Dept Urol, F-33076 Bordeaux, France
[4] Hop Pellegrin, Dept Radiol, F-33076 Bordeaux, France
[5] Hop Pellegrin, Dept Pathol, F-33076 Bordeaux, France
关键词
F-18]-fluorocholine; DWI; MRI; prostate cancer; staging; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; LYMPH-NODES; RADICAL PROSTATECTOMY; LOCALIZATION; INTERMEDIATE; NOMOGRAM; DISEASE;
D O I
10.1002/pros.22921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Accurate staging is important before surgical decision in patients with high-risk prostate cancer (PCa). The purpose of this study was to prospectively compare the diagnostic performance of F-18-FCholine and MRI with diffusion weighted imaging (DWIMRI) for local and regional lymph node (LN) staging before radical prostatectomy (RP) with extended pelvic lymphadenectomy (PLND). METHODS. We identified 47 patients who underwent F-18-FCholine and DWIMRI followed by surgical treatment (either prostatectomy or LN dissection or an association of prostatectomy and LN dissection) between May 2010 and December 2012 at Bordeaux University Hospital. These patients were part of a prospective study (EudraCT number 2009-014839-21) evaluating the interest of F-18-FCholine in staging of high-risk PCa. Diagnostic performances were retrospectively determined for each of F-18-FCholine and DWIMRI considering LN invasion, each of prostate sextants, capsular invasion and extension to seminal vesicles. F-18-FCholine and MR findings were correlated with histological findings. RESULTS. In a region-based LN analysis, the sensitivity and positive predictive value specificity were respectively, 56% and 98% for F-18-Choline, and 17% and 97% for DWIMRI. In a patient-based analysis the sensitivity and positive predictive value were respectively 78% and 94% for F-18-Choline and 33% and 84% for DWIMRI (P = 0.015). For tumor staging, DWIMRI showed better performances with a better specificity (69%) for sextants analysis and sensitivity to detect seminal vesicle invasion (73% vs. 36%). CONCLUSIONS. F-18-FCholine imaging appears to provide helpful additional information in the staging of high-risk PCa. It appears essential for predicting LN status due to its higher sensitivity and specificity for LN involvement. However, despite excellent performance, it cannot replace MRI that remains better for tumoral localization and local evaluation, especially for seminal vesicle invasion. PATIENT SUMMARY. This study highlights the interest of F-18-Choline in the staging of high risk prostate cancer in addition with DWI MRI, especially so in the evaluation of lymph node involvement due to its high sensitivity and excellent specificity. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 50 条
  • [11] 18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer
    Quero, Laurent
    Vercellino, Laetitia
    de Kerviler, Eric
    Mongiat-Artus, Pierre
    Culine, Stephane
    Merlet, Pascal
    Ravery, Vincent
    Meria, Paul
    Desgrandchamps, Francois
    Hennequin, Christophe
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (11) : e492 - e495
  • [12] 18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
    H. Kjölhede
    G. Ahlgren
    H. Almquist
    F. Liedberg
    K. Lyttkens
    T. Ohlsson
    O. Bratt
    World Journal of Urology, 2014, 32 : 965 - 970
  • [13] Validation of 3 T MRI including diffusion-weighted imaging for nodal staging of newly diagnosed intermediate- and high-risk prostate cancer
    von Below, C.
    Daouacher, G.
    Wassberg, C.
    Grzegorek, R.
    Gestblom, C.
    Sorensen, J.
    Ahlstrom, H.
    Walden, M.
    CLINICAL RADIOLOGY, 2016, 71 (04) : 328 - 334
  • [14] Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France
    Gauthe, Mathieu
    Zarca, Kevin
    Aveline, Cyrielle
    Lecouvet, Frederic
    Balogova, Sona
    Cussenot, Olivier
    Talbot, Jean-Noel
    Durand-Zaleski, Isabelle
    BMC MEDICAL IMAGING, 2020, 20 (01)
  • [15] Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France
    Mathieu Gauthé
    Kevin Zarca
    Cyrielle Aveline
    Frédéric Lecouvet
    Sona Balogova
    Olivier Cussenot
    Jean-Noël Talbot
    Isabelle Durand-Zaleski
    BMC Medical Imaging, 20
  • [16] Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer
    Kim, Jung Kwon
    Song, Yoo Sung
    Lee, Won Woo
    Lee, Hak Jong
    Hwang, Sung Il
    Hong, Sung Kyu
    PROSTATE INTERNATIONAL, 2022, 10 (03) : 152 - 157
  • [17] 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients
    Selnaes, Kirsten M.
    Kruger-Stokke, Brage
    Elschot, Mattijs
    Willoch, Frode
    Storkersen, Oystein
    Sandsmark, Elise
    Moestue, Siver A.
    Tessem, May-Britt
    Halvorsen, Dag
    Kjobli, Eirik
    Angelsen, Anders
    Langorgen, Sverre
    Bertilsson, Helena
    Bathen, Tone F.
    EUROPEAN RADIOLOGY, 2018, 28 (08) : 3151 - 3159
  • [18] Diagnostic and therapeutic impact of PET/CT with 18F-DCFPyL versus 18F-Fluorocholine in initial staging of intermediate-/high-risk prostate cancer: a pilot study
    Lucas, Cristina Lucas
    Zoghby, Laura Garcia
    Amo-Salas, Mariano
    Castrejon, angel Maria Soriano
    Vicente, Ana Maria Garcia
    ANNALS OF NUCLEAR MEDICINE, 2023, 37 (10) : 551 - 560
  • [19] Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer
    Kjolhede, Henrik
    Ahlgren, Goran
    Almquist, Helen
    Liedberg, Fredrik
    Lyttkens, Kerstin
    Ohlsson, Tomas
    Bratt, Ola
    BJU INTERNATIONAL, 2012, 110 (10) : 1501 - 1506
  • [20] Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
    Ingvar, Jacob
    Hvittfeldt, Erland
    Tragardh, Elin
    Simoulis, Athanasios
    Bjartell, Anders
    EJNMMI RESEARCH, 2022, 12 (01)